Chairman, Hydralyte
| Role | Organisation | Sources |
|---|---|---|
| Chairman | Hydralyte | BW Equities |
| Director of Strategy (former) | Swisse | BW Equities (14 Dec 2021), BW Equities (22 Nov 2021) |
Stories naming George Livery. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Hydration Pharmaceuticals, which sells Hydralyte in North America, listed on the ASX, raising $17 million at 29 cents and closing 22.4% higher. Former Swisse executives hold key roles and large stakes.
Hydralyte's pre-float raise has closed with backing from the Gandel family and two small-cap funds, pricing the hydration business at $46.7 million ahead of its listing; BW Equities handled the raise.